The choice of neuropeptide Y was deliberate. The 36-amino-acid peptide is a well-characterized brake on excitatory neurotransmission, toning down glutamate release at presynaptic terminals, and it has been proposed as a candidate therapeutic for anxiety disorders and post-traumatic stress disorder. The problem has always been delivery: peptides are fragile, diffuse poorly, and act promiscuously unless they can be steered to the right cells. The researchers turned to medical-grade graphene oxide, a two-dimensional carbon nanomaterial whose large surface area and versatile surface chemistry allow high loading of bioactive molecules. Crucially, they used small, thin nanosheets with lateral dimensions below one micrometer, a variant previously shown to be biocompatible with nervous tissue in vitro and in vivo and even degradable by immune cells after administration.

Building the complex was chemically simple but rigorously characterized. The team adjusted the pH of the nanosheet suspension to neutrality, added neuropeptide Y, and tested several mass ratios before settling on 10:4, the highest peptide load that remained colloidally stable. Unbound peptide was removed by repeated ultracentrifugation through 100-kilodalton cutoff filters, and quantification confirmed that essentially all of the starting nanosheet material was recovered with the peptide retained on its surface. Scanning electron microscopy showed that 95 percent of the sheets measured below 328 nanometers across, with a mean near 121 nanometers, while atomic force microscopy revealed thicknesses of only one to two nanometers, corresponding to single or double layers. X-ray photoemission spectroscopy detected the nitrogen signature of the peptide on the sheet surface, and X-ray diffraction showed the characteristic interlayer spacing of graphene oxide shifting as the peptide intercalated between sheets.

Perhaps the most striking materials result was stability. Dynamic light scattering and zeta potential measurements showed particles of roughly 200 nanometers with a strongly negative surface charge of about minus 50 millivolts, values that remained constant for more than 60 days. High-performance liquid chromatography found no detectable peptide detachment over 42 days of storage at room temperature, and even after two years, forced-detachment assays showed no measurable loss of peptide loading. The complex was also confirmed to be free of endotoxin contamination, a critical requirement for any material destined for the brain.

With the platform validated, the team moved to electrophysiology. In dissociated hippocampal cultures, a standard testing ground for vectorized delivery systems, they recorded excitatory postsynaptic currents from individual pyramidal neurons using patch-clamp pipettes while isolating glutamatergic events with a GABA receptor blocker. Applying either free neuropeptide Y or the nanosheet complex for five minutes produced a reversible depression of synaptic activity: normalized event frequencies fell to roughly half of baseline in both cases, and amplitudes dropped significantly, with washout restoring activity toward control levels. When the researchers repeated the experiment in the presence of selective antagonists for the Y1 and Y2 neuropeptide Y receptors, the depression vanished entirely, confirming that the complexed peptide was still acting through its native receptors and not through any intrinsic effect of the graphene oxide itself.

The next question was whether the complex could block synaptic plasticity, the cellular substrate of fear memory. In dissociated amygdala cultures, which express both Y1 and Y2 receptors, the team induced chemical long-term potentiation by briefly flooding the cells with glutamate while depolarizing the membrane. Untreated neurons responded with a robust, lasting increase in excitatory synaptic strength, with amplitudes rising to about 1.6 times baseline. When free neuropeptide Y or the nanosheet complex was applied before and during the induction protocol, that potentiation was completely prevented, with amplitudes remaining statistically indistinguishable from pre-induction baselines. The implication was clear: the peptide, whether free or riding on a nanosheet, could shut down the very form of synaptic strengthening that locks traumatic memories into amygdala circuits.

The in vivo experiments provided the conceptual centerpiece. Neuroanatomists distinguish two output pathways from the lateral amygdala: one projecting to the ventrolateral periaqueductal gray, which drives defensive fear responses, and another to the ventromedial hypothalamus, which regulates anxiety. Using a fluorescent retrograde tracer injected into each target region, the researchers confirmed that only the fear pathway, the projection to the periaqueductal gray, expresses the Y1 receptor, while the anxiety pathway lacks it. This differential receptor expression offered a molecular handle for selective pharmacology: a ligand for Y1 receptors should silence fear circuits while sparing anxiety circuits.

To test this, the team used a rat model of post-traumatic stress disorder in which exposure to a cat-worn collar, a predator odor, triggers lasting fear and anxiety behaviors. Rats exposed to the odor showed a marked increase in head-out defensive scanning when re-exposed to the context eight days later, a hallmark of consolidated aversive memory. Injecting either free neuropeptide Y or the nanosheet complex directly into the lateral amygdala abolished this defensive response, while rats given saline remained fearful. Yet on the elevated plus maze, a standard test of anxiety, all odor-exposed groups, including those treated with the complex, still showed heightened anxiety-like behavior, spending less time on the open arms. Open field testing confirmed no changes in locomotion, ruling out motor impairment as a confound. The specificity was further reinforced by control experiments: blocking Y1 receptors with the antagonist BIBO 3304, or substituting a scrambled peptide sequence on the nanosheets, eliminated the fear-memory effect entirely.

The authors argue that these results consolidate a picture in which stress-related behaviors are carried by anatomically and neurochemically distinct pathways that can be pharmacologically separated. Because the nanosheet complex lost the intrinsic glutamate-modulating activity that pristine graphene oxide displays on its own, and because its effects vanished in the presence of receptor antagonists, the team concludes that the peptide remains largely associated with the nanosheet during its biological action, whether by being presented to receptors or released locally. The current experiments cannot fully discriminate between those two mechanisms, a limitation the authors acknowledge openly.

The therapeutic horizon is nonetheless considerable. Intracranial injection, as used here, is not a practical route for patients, but the researchers suggest that complexing peptides to graphene oxide might improve crossing of biological barriers and preserve peptide bioavailability through less invasive routes such as intravenous or intranasal administration. The versatile surface chemistry of graphene oxide also opens the door to multifunctional carriers loaded with several molecules at once, potentially enabling combined therapeutic and diagnostic platforms aimed at precise targets in the central nervous system. For a field where targeted drug delivery to defined neural circuits has remained an aspiration more than an achievement, a flat carbon nanosheet quietly ferrying a neuropeptide to exactly the right synapses is a result worth watching.

Subject of Research: Graphene oxide nanosheet delivery of neuropeptide Y to selectively inhibit fear memory circuits in the amygdala

Article Title: Neuropeptide Y—Graphene Oxide Complexes Inhibit Amygdala NPY‐Receptor Expressing Glutamatergic Pathways and Selectively Remove Aversive Memory In Vivo

Article References: Pati, E., Franceschi Biagioni, A., Casani, R., Arellano, L. M., Battisti, T., Garcia‐Ortega, G., Lozano, N., Bianco, A., Kostarelos, K., Ballerini, L., & Cellot, G. (2026). Neuropeptide Y—Graphene Oxide Complexes Inhibit Amygdala NPY‐Receptor Expressing Glutamatergic Pathways and Selectively Remove Aversive Memory In Vivo. Advanced Science, 13(56), Article e76608. https://doi.org/10.1002/advs.76608

Image Credits: AI Generated

DOI: 10.1002/advs.76608

Keywords: graphene oxide, neuropeptide Y, drug delivery, amygdala, fear memory, PTSD, synaptic plasticity, long-term potentiation, nanomedicine, glutamatergic transmission, Y1 receptor, neuroscience

The research team set out to test whether the famous separation principle holds equally along the full length of the hippocampus, a seahorse-shaped structure deep in the brain that is essential for storing memories of places and events. Neuroscientists have long divided the hippocampus into a dorsal pole, which in rodents and humans is heavily involved in fine-grained spatial and cognitive processing, and a ventral pole, which is more intimately connected with emotion, stress, and fear circuitry. The two regions differ in their connectivity, their gene expression profiles, and even the electrical properties of their principal neurons. Yet most theories of memory encoding were built on data from the dorsal end, leaving a crucial question unanswered: does the emotional half of the hippocampus follow the same coding rules as the cognitive half?

To find out, the researchers turned to a state-of-the-art combination of behavioral design and miniaturized calcium imaging. They implanted tiny microscopes onto the heads of mice and tracked the activity of hundreds of individual neurons in CA1 — the hippocampus’s main output layer — in both the dorsal and ventral regions simultaneously. Each mouse learned to associate one experimental context, designated context A, with mild foot shocks, while a second, visually distinct context B remained neutral and safe. The animals responded exactly as expected, freezing with fear in context A and exploring calmly in context B. But the neural story underneath that behavior proved far more surprising than any textbook prediction.

When the researchers compared the population activity patterns — the combined firing fingerprints of all recorded neurons — before and after fear conditioning, they found that both dorsal and ventral CA1 changed their representations of the shock-paired environment. Fear learning literally rewrote the spatial map. The critical difference was magnitude. In ventral CA1, the representational shift was substantially larger than in dorsal CA1, and the size of the shift scaled with how strongly each mouse froze: the more the animal feared the context, the more dramatically its ventral map had reorganized. The dorsal maps also changed, but they retained their hallmark quality of staying crisp and stable across repeated exposures.

The real challenge to the canonical theory came during discrimination testing, when mice were shuttled between the threatening and neutral contexts. In dorsal CA1, the two context representations remained clearly distinct, exactly as pattern separation theory demands. In ventral CA1, however, the opposite occurred: the representations of the dangerous and the safe environment became more similar to each other. Rather than pushing the two memories apart to prevent interference, fear learning in the ventral hippocampus pulled them together, creating a zone of overlap between the neural code for threat and the neural code for safety.

The authors interpret this overlap through the mathematical language of attractor dynamics — a framework borrowed from theoretical neuroscience in which stable patterns of network activity behave like valleys in an energy landscape. A neural representation, on this view, is a basin into which activity naturally settles, and the deeper and more sharply separated the basins, the more energy it takes to jump between them. Before fear conditioning, both dorsal and ventral CA1 hold well-separated context representations, and switching between them requires crossing a substantial energy barrier. After conditioning, dorsal CA1’s landscape is essentially unchanged. But ventral CA1’s landscape flattens: the basin corresponding to the threatening context widens and migrates closer to the neutral one, opening more entry points and lowering the energy required to fall into the fear state.

The consequence of this shallower landscape is speed, and the study demonstrates it directly. By analyzing how quickly each region reinstated the threatening context representation when mice transitioned back into context A, the researchers found that ventral CA1 expressed the fear-context code faster and more strongly than dorsal CA1. Even more striking, the relative dominance of the threatening versus neutral representation in ventral CA1 predicted how much each mouse actually froze — a direct link between the geometry of neural codes and the expression of fear behavior. When mice moved into the neutral context, the same logic ran in reverse: ventral CA1 showed the most rapid and pronounced suppression of the threatening representation among the regions examined, consistent with overlapping codes being quick to both engage and disengage.

It is tempting to see this as a computational trade-off, and the authors make that trade-off explicit. Pattern separation and pattern completion have always been two sides of the same coin in hippocampal theory: separating representations guards against interference, while allowing representations to blend permits a memory to be triggered by partial or ambiguous cues. The ventral hippocampus, this work suggests, tilts the balance heavily toward completion. For an animal whose survival depends on detecting danger quickly, the cost of occasionally mistaking a safe context for a dangerous one may be far smaller than the cost of failing to recognize a lethal threat in time. Rapid retrieval of fear memories, even at the price of some discriminative precision, may be an evolutionarily rational bargain.

The findings also help resolve a long-standing tension in the literature on hippocampal fear. Earlier work showed that ventral CA1 contains ensembles whose correlated activity retrieves contextual fear memories, that ventral hippocampal projections to the prefrontal cortex and amygdala regulate anxiety and avoidance, and that inactivating the ventral hippocampus alters fear expression and extinction. What remained unclear was how these emotional functions coexisted with the region’s evident role in spatial coding. The new results propose a unifying principle: the ventral hippocampus encodes space, but it warps its spatial codes in the service of valence, reshaping them so that emotionally significant environments become easier to summon from memory.

The implications extend beyond basic science. Overlapping or overly generalized context representations are a suspected hallmark of maladaptive fear in conditions such as post-traumatic stress disorder, where innocuous environments come to trigger full-blown threat responses. If the ventral hippocampal mechanism described here generalizes to humans, therapies aimed at restoring separability between threat and safety codes — rather than merely dampening fear output — could offer a more targeted route to treatment. For now, the study delivers its most memorable lesson in the cleanest terms: sometimes the brain remembers better not by keeping memories apart, but by letting danger and safety share the same neural ground, ready to tip into fear the instant the world turns threatening.

Subject of Research: How fear learning reshapes spatial context representations in the ventral versus dorsal hippocampus to enable rapid fear memory retrieval in mice

Article Title: Overlapping representations in the ventral hippocampus support rapid fear memory retrieval

Article References: Rozeske, R. R., Runtz, L., Lee, J. Q., Keinath, A. T., Sossin, A., & Brandon, M. P. (2026). Overlapping representations in the ventral hippocampus support rapid fear memory retrieval. Nature Neuroscience. https://doi.org/10.1038/s41593-026-02435-5

Image Credits: AI Generated

DOI: 10.1038/s41593-026-02435-5

Keywords: hippocampus, fear conditioning, memory retrieval, place cells, calcium imaging, attractor dynamics, pattern separation, ventral CA1, dorsal CA1, neuroscience, spatial memory, contextual fear